Literature DB >> 26550528

New targets for controlling Ebola virus disease.

F Xiao-Feng Qin1, Cheng-Yu Jiang2, Taijiao Jiang3, Genhong Cheng4.   

Abstract

Entities:  

Year:  2015        PMID： 26550528      PMCID： PMC4632854          DOI： 10.1093/nsr/nwv043

Source DB:  PubMed          Journal:  Natl Sci Rev        ISSN： 2053-714X            Impact factor:   17.275


× No keyword cloud information.
  10 in total

1.  Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Authors:  Yasuteru Sakurai; Andrey A Kolokoltsov; Cheng-Chang Chen; Michael W Tidwell; William E Bauta; Norbert Klugbauer; Christian Grimm; Christian Wahl-Schott; Martin Biel; Robert A Davey
Journal:  Science       Date:  2015-02-27       Impact factor: 47.728

2.  Network of co-mutations in Ebola virus genome predicts the disease lethality.

Authors:  Lizong Deng; Mi Liu; Sha Hua; Yousong Peng; Aiping Wu; F Xiao-Feng Qin; Genhong Cheng; Taijiao Jiang
Journal:  Cell Res       Date:  2015-05-15       Impact factor: 25.617

3.  Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Authors:  Lisa A Lopez; Su Jung Yang; Colin M Exline; Srinivas Rengarajan; Kevin G Haworth; Paula M Cannon
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

4.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol.

Authors:  Su-Yang Liu; Roghiyh Aliyari; Kelechi Chikere; Guangming Li; Matthew D Marsden; Jennifer K Smith; Olivier Pernet; Haitao Guo; Rebecca Nusbaum; Jerome A Zack; Alexander N Freiberg; Lishan Su; Benhur Lee; Genhong Cheng
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

Review 5.  Small molecule inhibitors of ebola virus infection.

Authors:  Edwige Picazo; Fabrizio Giordanetto
Journal:  Drug Discov Today       Date:  2014-12-19       Impact factor: 7.851

Review 6.  Camouflage and misdirection: the full-on assault of ebola virus disease.

Authors:  John Misasi; Nancy J Sullivan
Journal:  Cell       Date:  2014-10-16       Impact factor: 41.582

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

8.  Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro.

Authors:  MiaoMiao Sheng; Ying Zhong; Yang Chen; JianChao Du; XiangWu Ju; Chen Zhao; GuiGen Zhang; LiFang Zhang; KangTai Liu; Ning Yang; Peng Xie; DangSheng Li; Michael Q Zhang; ChengYu Jiang
Journal:  Sci China Life Sci       Date:  2014-09-13       Impact factor: 6.038

9.  The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.

Authors:  Annika Kühl; Carina Banning; Andrea Marzi; Jörg Votteler; Imke Steffen; Stephanie Bertram; Ilona Glowacka; Andreas Konrad; Michael Stürzl; Ju-Tao Guo; Ulrich Schubert; Heinz Feldmann; Georg Behrens; Michael Schindler; Stefan Pöhlmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 10.  Lipids in innate antiviral defense.

Authors:  John W Schoggins; Glenn Randall
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023
  10 in total
  2 in total

1.  A fungal dioxygenase CcTet serves as a eukaryotic 6mA demethylase on duplex DNA.

Authors:  Yajuan Mu; Lin Zhang; Jingyan Hu; Jiashen Zhou; Hou-Wen Lin; Chuan He; Hong-Zhuan Chen; Liang Zhang
Journal:  Nat Chem Biol       Date:  2022-06-02       Impact factor: 16.174

2.  CRISPR/Cas9-based generation of a recombinant double-reporter pseudorabies virus and its characterization in vitro and in vivo.

Authors:  Peng-Fei Fu; Xuan Cheng; Bing-Qian Su; Li-Fang Duan; Cong-Rong Wang; Xin-Rui Niu; Jiang Wang; Guo-Yu Yang; Bei-Bei Chu
Journal:  Vet Res       Date:  2021-06-26       Impact factor: 3.683
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.